AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Summary

This phase II trial is studying how well AZD0530 works in treating patients with prostate cancer that did not respond to hormone therapy. AZD0530 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth

Timeline

Start

2007-08

Primary completion

2008-10

Completion

2008-10

Drugs

Indications